Advertisement

Topics

CANTOS: Canakinumab Fails to Prevent New-Onset Diabetes

07:21 EDT 14 Mar 2018 | Medscape

However, the anti-inflammatory drug helped put patients with diabetes and CKD on equal footing for CV events as those without these high-risk conditions.
Medscape Medical News

Original Article: CANTOS: Canakinumab Fails to Prevent New-Onset Diabetes

NEXT ARTICLE

More From BioPortfolio on "CANTOS: Canakinumab Fails to Prevent New-Onset Diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...